(December 13, 2016, 1:31 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Dec. 12 said an updated review of medical studies has led it to conclude that the diabetes drug Actos may be...
FDA Concludes Actos Is Linked To Bladder Cancer After Literature Review
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login